Acute promyelocytic leukemia classification

Revision as of 03:07, 29 April 2018 by Shyam Patel (talk | contribs)
Jump to navigation Jump to search

Acute promyelocytic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute promyelocytic leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary PreventionSurgery

Secondary PreventionSurgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute promyelocytic leukemia classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute promyelocytic leukemia classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute promyelocytic leukemia classification

CDC on Acute promyelocytic leukemia classification

Acute promyelocytic leukemia classification in the news

Blogs on Acute promyelocytic leukemia classification

Directions to Hospitals Treating Acute promyelocytic leukemia

Risk calculators and risk factors for Acute promyelocytic leukemia classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Classification=

  • Low-risk disease: Low-risk disease is defined as the presence of less than 10000 white blood cells per microliter in peripheral blood.[1]
  • High-risk disease: Low-risk disease is defined as the presence of greater than 10000 white blood cells per microliter in peripheral blood.[1]

References

  1. 1.0 1.1 Coombs CC, Tavakkoli M, Tallman MS (2015). "Acute promyelocytic leukemia: where did we start, where are we now, and the future". Blood Cancer J. 5: e304. doi:10.1038/bcj.2015.25. PMC 4450325. PMID 25885425.

Template:WH Template:WS